Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-10-005089
Filing Date
2010-02-17
Accepted
2010-02-17 16:11:55
Documents
2
Period of Report
2010-02-12

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 4255
2 POWER OF ATTORNEY doc1.txt EX-24 4166
  Complete submission text file 0001127602-10-005089.txt   10377
Mailing Address 14 CAMBRIDGE CENTER CAMBRIDGE MA 02142
Business Address 14 CAMBRIDGE CENTER CAMBRIDGE MA 02142 6176792000
BIOGEN IDEC INC. (Issuer) CIK: 0000875045 (see all company filings)

EIN.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O BIOGEN IDEC INC. 14 CAMBRIDGE CENTER CAMBRIDGE MA 02142
Business Address
Clancy Paul J (Reporting) CIK: 0001409601 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19311 | Film No.: 10612941